Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma

Completed · Phase 2

Conditions studied: Adult Brain Tumor

In brief

RATIONALE: Current therapies for adults with anaplastic astrocytoma provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of adults with anaplastic astrocytoma. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on adults with anaplastic astrocytoma.

Key facts

Study ID

NCT00003537

Run by

Burzynski Research Institute

People needed

19

Starts

1995-04-01

Expected to finish

2008-10-01

Last updated by the study team

2017-08-24

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Burzynski Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.